{
  "documentMetadata": {
    "title": "Chronic Bacterial Prostatitis",
    "sourceFile": "Prostatitis, Bacterial, Chronic.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Low grade fever, urinary frequency, dysuria, urgency, perineal discomfort.",
        "Chronic infection and positive urine or prostatic fluid cultures.",
        "See comments section for management of chronic pain syndrome or chronic prostatitis without infection.",
        "Reference: Clin Infect Dis 50: 1641, 2010."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Enterobacteriaceae (80%)",
        "Enterococci (15%)",
        "P. aeruginosa",
        "Burkholderia pseudomallei (uncommon; usually in acute prostatitis)"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "components": [
          {
            "drug": "Ciprofloxacin",
            "dose": "500 mg",
            "route": "po",
            "frequency": "bid",
            "duration": "4 weeks"
          },
          {
            "drug": "Levofloxacin",
            "dose": "750 mg",
            "route": "po",
            "frequency": "q24h",
            "duration": "4 weeks",
            "connector": "or"
          }
        ],
        "notes": "(see Comment re higher dose than approved)"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Alternative",
        "components": [
          {
            "drug": "TMP-SMX-DS",
            "dose": "1 tab",
            "route": "po",
            "frequency": "bid",
            "duration": "1-3 months"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Alternative",
        "condition": "if C. Trachomatis suspected",
        "components": [
          {
            "drug": "Azithromycin"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Levofloxacin: FDA approved dose is 500 mg; editors prefer 750 mg dose because of higher drug levels and reports of treatment failures at the lower dose.",
        "Urine culture is important; for best results collect urine after prostatic massage.",
        "With treatment failures consider infected prostatic calculi.",
        "Management of chronic prostatitis: Reviewed Canadian Urol Assoc J (6 Suppl 3): S161, 2018",
        "Confirm diagnosis",
        "Multimodal therapeutic approach",
        "Use the \"5 A's\"",
        "Avoid dietary or physical activities (e.g., bike riding) that exacerbate symptoms",
        "Antibiotics (if 4 week Rx fails, no further antimicrobials should be used unless confirmed UTI)",
        "Alpha-blockers: Part of a multimodal treatment plan",
        "Anti-inflammatory agents: Part of a multimodal treatment plan",
        "5-alpha reductase inhibitors: Only in men > 50 years and enlarged prostate on exam",
        "Management of chronic pain syndrome, chronic prostatitis without infection (Chronic Prostate Pain Syndrome (CPPS): Reviewed Am J Mens Health: 14, 2020)",
        "Most common prostatic syndrome.",
        "Patient presents symptoms of prostatitis but negative cultures and no cells in prostatic secretions.",
        "Etiology unknown.",
        "Antimicrobial therapy not recommended.",
        "Case reports that Fosfomycin penetrates prostate and success with 3 gm po once daily x 12-16 weeks (Clin Infect Dis 61: 1141, 2015). Another 15 patients responded to 3 gm po q48-72 hrs x 6 weeks (Antimicrob Ag Chemother 60:1854, 2016). Fosfomycin may be an oral option if no other alternatives (e.g., ESBL-producing organism, as in these cases).",
        "Excellent Review: BJU International 116:509, 2015."
      ]
    }
  ]
}